Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes

Polskie Archiwum Medycyny Wewnetrznej

Volumn 121, Issue 3, 2011, Pages 67-72

  Samborski, Paweł ^a   Naskrȩt, Dariusz ^a   Araszkiewicz, Aleksandra ^a   Niedźwiecki, Paweł ^a   Zozulińska Ziółkiewicz, Dorota ^a   Wierusz Wysocka, Bogna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Advanced glycation end products; Autofluorescence; Diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; AUTOFLUORESCENCE; BIOACCUMULATION; CONTROLLED STUDY; DIABETES CONTROL; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; METABOLIC REGULATION;

EID: 79954556480     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1025     Document Type: Article

References (21)

1. Vlassara H, Palace MR. Diabetes and advanced glycation endproducts. J Intern Med. 2002; 251: 87-101. (Pubitemid 34146691)
2. Meerwaldt R, Links T, Zeebregts C, et al. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc Diabetol. 2008; 7: 29.
3. Uribarri J, Cai W, Sandu O, et al. Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci. 2005; 1043: 461-466. (Pubitemid 41123934)
4. Cerami C, Founds H, Nicholl I, et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A. 1997; 94: 13 915-13 920.
5. Miyata T, van Ypersele de Strihou C, Kurokawa K, et al. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int. 1999; 55: 389-399.
6. Lindsey JB, de Lemos JA, Cipollone F, et al. Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study. Diabetes Care. 2009; 32: 1218-1220.
7. Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004; 63: 582-592. (Pubitemid 39078671)
8. Semba RD, Ferrucci L, Sun K, et al. Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women. Aging Clin Exp Res. 2009; 21: 182-190.
9. Monnier VM, Vishwanath V, Frank KE, et al. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med. 1986; 314: 403-408. (Pubitemid 16161885)
10. Lutgers HL, Graaff R, Links TP, et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care. 2006; 29: 2654-2659. (Pubitemid 44912194)
11. Meerwaldt R, Links TP, Graaff R, et al. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia. 2005; 48: 1637-1644. (Pubitemid 41175518)
12. Meerwaldt R, Graaff R, Oomen PH, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia. 2004; 47: 1324-1330. (Pubitemid 39093330)
13. Mulder DJ, van Haelst PL, Graaff R, et al. Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events. Neth Heart J. 2009; 17: 162-168.
14. Greven WL, Smit JM, Rommes JH, Spronk PE. Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study. BMC Clin Pathol. 2010; 10: 4.
15. de Leeuw K, Graaff R, de Vries R, et al. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2007; 46: 1551-1556. (Pubitemid 47500568)
16. Ueno H, Koyama H, Tanaka S, et al. Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease. Metabolism. 2008; 57: 1452-1457.
17. Kass DA, Shapiro EP, Kawaguchi M, et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation. 2001; 104: 1464-1470. (Pubitemid 32917336)
18. Drzewoski J, Kasznicki J, Trojanowski Z. The role of "metabolic memory" in the natural history of diabetes mellitus. Pol Arch Med Wewn. 2009; 119: 493-500.
19. Monami M, Lamanna C, Gori F, et al. Skin autofluorescence in type 2 diabetes: beyond blood glucose. Diabetes Res Clin Pract. 2008; 79: 56-60.
20. Meerwaldt R, Lutgers HL, Links TP, et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care. 2007; 30: 107-112. (Pubitemid 46052507)
21. Homa K, Majkowska L. Difficulties in interpreting HbA1c results. Pol Arch Med Wewn. 2010; 120: 148-154.